Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

298.94
+3.941.33%
Volume:35.45K
Turnover:10.60M
Market Cap:5.96B
PE:30.79
High:301.96
Open:294.79
Low:294.32
Close:295.00
52wk High:326.63
52wk Low:175.89
Shares:19.94M
Float Shares:19.35M
Volume Ratio:0.37
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:6.16
PE(LYR):48.77

Loading ...

Ligand proposes offering USD 550 million of convertible senior notes due 2031

Reuters
·
Jun 22

Ligand Pharmaceuticals - Initial Purchasers Granted 13-Day Option to Buy up to $82.5 Mln Additional Notes

THOMSON REUTERS
·
Jun 22

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 22

Ligand Pharmaceuticals - to Use up to $75 Mln of Proceeds for Common Stock Repurchase

THOMSON REUTERS
·
Jun 22

Ligand Pharmaceuticals - to Use Part of Proceeds for Convertible Note Hedge Transactions

THOMSON REUTERS
·
Jun 22

Ligand Pharmaceuticals (LGND) Is Up 7.6% After Institutions Snap Up the Float and Earnings Jump – Has The Bull Case Changed?

Simply Wall St.
·
Jun 20

Ligand Pharma director Stephen L. Sabba disposes of common shares worth $544,830

Reuters
·
Jun 18

Ligand Pharmaceuticals director Jason Haas reports sale of 6,461 common shares worth $1.65 million

Reuters
·
Jun 16

Pelthos Therapeutics director Todd C. Davis buys USD 999,994 of common stock

Reuters
·
Jun 16

Ligand Pharma director Jason Aryeh disposes of 5,000 common shares worth $1.25 million

Reuters
·
Jun 13

Ligand Pharma director John L. LaMattina disposes of 4,591 common shares worth $1.15 million

Reuters
·
Jun 13

Ligand to host investor day webcast for shareholders

Reuters
·
Jun 10

Ligand Pharmaceuticals stockholders approve restated 2002 stock incentive plan at annual meeting

Reuters
·
Jun 10

Is Ligand Pharmaceuticals (LGND) Still Undervalued After Its Strong Recent Share Price Momentum

Simply Wall St.
·
Jun 07

Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Tenaya Therapeutics (TNYA)

TIPRANKS
·
Jun 04

Ligand CLO, Secretary Andrew Reardon sells USD 1.11 million in common shares

Reuters
·
Jun 03

BofA Securities Adjusts Ligand Pharmaceuticals Price Target to $266 From $263

MT Newswires Live
·
May 28

Ligand Pharma (LGND) Receives a Buy from Bank of America Securities

TIPRANKS
·
May 28

Ligand Pharmaceuticals to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 28

Xoma downgraded to Hold from Buy at Benchmark

TIPRANKS
·
May 22